Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,208 | -3,540 | -1,679 | -8,374 | -6,654 |
| Depreciation Amortization | 142 | 90 | 45 | 184 | 138 |
| Accounts receivable | 72 | -484 | -100 | 563 | 1,149 |
| Other Working Capital | 714 | 63 | 43 | 308 | 619 |
| Other Operating Activity | 357 | 803 | 284 | 684 | -420 |
| Operating Cash Flow | $-3,923 | $-3,067 | $-1,407 | $-6,637 | $-5,169 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -30 | -30 | N/A | N/A | N/A |
| Common Stock Issued | 729 | 591 | 315 | 5,116 | 4,632 |
| Common Stock Repurchased | -76 | N/A | -10 | -285 | -214 |
| Other Financing Activity | 0 | -44 | 0 | 0 | 0 |
| Financing Cash Flow | $624 | $517 | $306 | $4,830 | $4,418 |
| Exchange Rate Effect | -21 | -13 | 7 | 77 | 117 |
| Beginning Cash Position | 5,361 | 5,361 | 5,361 | 7,091 | 7,091 |
| End Cash Position | 2,041 | 2,800 | 4,268 | 5,361 | 6,457 |
| Net Cash Flow | $-3,321 | $-2,562 | $-1,094 | $-1,730 | $-634 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,923 | -3,067 | -1,407 | -6,637 | -5,169 |
| Free Cash Flow | -3,923 | -3,067 | -1,407 | -6,637 | -5,169 |